Modulation of anxiety by mu-opioid receptors of the lateral septal region in mice

Pharmacology, Biochemistry, and Behavior
Julie Le MerrerPierre Cazala

Abstract

Morphine and opiates are known to exert anxiolytic effects, probably by interacting with the GABAergic system. The lateral septum (LS), mainly constituted of GABA neurons, exhibits high densities of mu-opiate receptors and could thus represent one the brain sites where opiates interact with GABAergic transmission to modulate anxiety. We examined the effects of intra-LS morphine injections on measures of anxiety using the elevated plus-maze and hole-board tests. Fos imaging was used to identify neural circuits involved in anxiety modulation. Unilateral intra-LS morphine (100 or 500 ng/100 nl) decreased open-arm exploration in the plus-maze and reduced head-dipping frequency in the hole-board, an anxiogenic-like effect associated with decreased Fos expression in the ventral LS, the dorsal hippocampus and the anterior hypothalamus. Anatomical specificity was assessed by injecting morphine into the medial septum, which failed to produce anxiogenesis. Pre-injection of the mu-opioid receptor antagonist naloxonazine (100 ng/100 nl) into LS reversed morphine-induced anxiogenesis and the associated pattern of Fos expression, indicating a specific recruitment of mu-opioid receptors by morphine. Surprisingly, bilateral morphine injections...Continue Reading

References

Oct 14, 1975·Psychopharmacologia·S E File, A G Wardill
Jun 1, 1989·Cell and Tissue Research·B OnténienteA Calas
Jan 1, 1987·Psychopharmacology·R G Lister
Jan 1, 1984·The Journal of Comparative Neurology·P PanulaE Costa
Jun 1, 1993·Physiology & Behavior·E YadinC E Strickland
Jun 7, 1996·Science·P Y Risold, L W Swanson
Jun 20, 1996·European Journal of Pharmacology·M TsudaH Nagase
Dec 31, 1997·Brain Research. Brain Research Reviews·P Y Risold, L W Swanson
Aug 7, 1998·Neuroreport·A AsakawaM Kasuga
Dec 3, 1999·The European Journal of Neuroscience·A M OuagazzalS E File
Jan 14, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·W KangM A Wilson
Aug 18, 2001·Pharmacology, Biochemistry, and Behavior·A DegrootD Treit
Feb 7, 2002·Pharmacology, Biochemistry, and Behavior·Newton S Canteras
Dec 31, 2002·Brain Research. Brain Research Reviews·David H Zald
Feb 20, 2004·Brain Research·Aldemar Degroot, Dallas Treit
Aug 7, 2004·Brain Research. Brain Research Reviews·Teige P SheehanDavid S Russell
Aug 9, 2005·Pharmacology, Biochemistry, and Behavior·Camilla L PattiVanessa C Abílio
Oct 21, 2005·Basic & Clinical Pharmacology & Toxicology·Mohammad-Reza ZarrindastAli Roohbakhsh

❮ Previous
Next ❯

Citations

Nov 27, 2010·Neuropharmacology·Maria Hadjiconstantinou, Norton H Neff
May 8, 2007·Physiology & Behavior·Gui-Hai ChenJiang-Ning Zhou
Mar 3, 2007·Pharmacological Reviews·Jakub FichnaJean-Claude Do Rego
Jul 28, 2015·Journal of Neuroendocrinology·C J W SmithA H Veenema
Apr 14, 2021·Neuroscience and Biobehavioral Reviews·Hannah S Wirtshafter, Matthew A Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.